Akhmad Karis Nugroho

Title: Akhmad Karis Nugroho: Innovator in Iontophoretic Drug Delivery

Introduction

Akhmad Karis Nugroho is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of medical technology, particularly in the treatment of Parkinson's disease. His innovative approach to drug delivery systems has garnered attention in the scientific community.

Latest Patents

Akhmad holds a patent for the "Iontophoretic delivery of rotigotine for the treatment of Parkinson's disease." This patent describes a composition that includes rotigotine and at least one chloride salt in a concentration of 1 to 140 mmol/l, with a pH of 4 to 6.5. The invention allows for a higher flux of rotigotine across the human stratum corneum compared to conventional passive diffusion systems, enhancing the effectiveness of treatment for Parkinson's disease.

Career Highlights

Akhmad is associated with Schwarz Pharma AG, where he continues to develop innovative solutions in pharmacology. His work focuses on improving drug delivery methods, which can significantly impact patient care and treatment outcomes.

Collaborations

Akhmad collaborates with esteemed colleagues such as Gai Ling Li and Johanna Aaltje Bouwstra. Their combined expertise contributes to advancing research and development in the field of drug delivery systems.

Conclusion

Akhmad Karis Nugroho's contributions to the field of medical technology, particularly through his patent on iontophoretic drug delivery, highlight his role as an innovator. His work promises to enhance treatment options for patients with Parkinson's disease and reflects the importance of innovation in healthcare.